« previous next »
Pages: [1]

Author Topic: (Abst.) Risk of infection in PwMS treated w/DMT: A Delphi consensus statement  (Read 85 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9842
  • MS diagnosed 1980
  • Location: Pacific Northwest
(Abst.) Risk of infection in PwMS treated w/DMT: A Delphi consensus statement
« on: September 22, 2020, 08:04:07 pm »
From Multiple Sclerosis Journal  (September 17, 2020), "The risk of infections in patients with multiple sclerosis treated with disease-modifying therapies: A Delphi consensus statement":


https://journals.sagepub.com/doi/abs/10.1177/1352458520952311


Delphi method:


https://en.wikipedia.org/wiki/Delphi_method


We don't really find out from the abstract just what was concluded but nonetheless this abstract does show that infections in MS are a continuing concern, in relation to the disease-modifying therapies.
« Last Edit: September 22, 2020, 08:06:32 pm by agate »
Report to moderator   Logged
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20 - 3/16/24.
Pages: [1]
« previous next »
 

Related Topics

  Subject / Started by Replies Last post
0 Replies
85 Views 		Last post November 02, 2018, 07:33:40 am
by agate
2 Replies
133 Views 		Last post October 17, 2019, 09:09:54 pm
by agate
0 Replies
66 Views 		Last post May 15, 2020, 12:36:31 pm
by agate
0 Replies
45 Views 		Last post June 18, 2021, 07:00:49 pm
by agate
0 Replies
51 Views 		Last post September 11, 2021, 09:48:44 pm
by agate